In pet genetics, cancer research, and beyond, Charlie Lieu, MBA ’05, SM ’05, has spent her career harnessing massive data ...
Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...
Scientists may finally be closing in on the origins of two colossal, mysterious structures buried nearly 1,800 miles inside Earth—hidden formations that have puzzled researchers for decades. New ...
A controlled test compared three nearly identical pages: one with strong schema, one with poor schema, and one with none. Only the page with well-implemented schema appeared in an AI Overview and ...
MathWorks, a leading developer of mathematical simulation and computing software, revealed that a ransomware gang stole the data of over 10,000 people after breaching its network in April. The company ...
TORONTO--(BUSINESS WIRE)--Structure Research, a leading independent research firm focused on cloud and data centre infrastructure, has released its latest reports: the Kuala Lumpur DCAI Report 2025: ...
In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...
Section 1. Policy and Purpose. My Administration has inaugurated a golden age for American manufacturing and technological dominance. We will pursue bold, large-scale industrial plans to vault the ...
NEW YORK--(BUSINESS WIRE)--KBRA releases research examining the differences between asset-backed securities (ABS) and commercial mortgage-backed securities (CMBS) for data center transactions, ...
Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results